HCA
HCA Healthcare Inc
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 413.36
Buy <=wait / entry
USD 366.67
Trim >=take some off
USD 420.00
Thesis breakThe thesis would be invalidated by a downgrade of FY 2026 EPS guidance below the...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 32% | 100 / 100 | 32.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 19% | 10 / 100 | 1.9 |
| Weighted conviction | 64 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Q2 2026 revenues increased 8.7% to $20.230 billion
- Diluted EPS increased 11.6% to $7.62 and adjusted EPS increased 11.0% to $7.59
- Cash flows from operating activities declined to $2.335 billion from $4.210 billion